LAB

Standard BioTools Inc

$0.71

0.02 (2.29%) Today

— up— down

Compare LAB

Market Cap

$280M-43.8%

Revenue (TTM)

$84.71M-45.1%

Net Income (TTM)

$85.42M

EPS (TTM)

0.22

Shares Out

391.46M

P/E Ratio

3.36

Open

$0.71

Previous Close

$0.73

Day Range

$0.71 – $0.73

52-Week Range

$0.63 – $1.72

Beta

1.56

Volume

173.44K

Avg Volume

2.83M

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About LAB

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.